
Therapeutic Segment
Anticonvulsant
CAS No.
102767-28-2
Regulatory Filing
USDMF, CEP
Development Status
DMF Filed
Molecule Type
Small Molecule
Mechanism of Action
Levetiracetam acts by modulation of synaptic neurotransmitter release through binding to the synaptic vesicle protein SV2A in the brain.